Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma

R. Crocchiolo, L. Castagna, S. Fürst, J. El-Cheikh, C. Faucher, C. Oudin, A. Granata, R. Bouabdallah, D. Coso, C. Chabannon, M. Balzarotti, A. Santoro, D. Blaise

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences